#pegylated interferon

Rick Nash’s journey, born with Hep C, six treatments for Hepatitis C (HCV,) one transplant, and lots of friends and family.

This Ukrainian woman didn’t let outdated hepatitis C treatment or limited access to them, prevent her from getting necessary medical care.

Fighting Hep C, using the fury to stoke the fire within.

This hep story teller and her husband describe their hepatitis C treatments using peginterferon and ribavirin as a wild ride.

A look at the latest hepatitis C treatment for children and teens.

As a hepatitis C navigator, Glenna McCarthy highlights the importance of self-care.

This hepatitis C survivor was cured with peginterferon and ribavirin; then she went on to help others who are suffering with hep C.

Former NFL star turned activist Rolf Benirschke kicks hepatitis C.

The FDA has approved Olysio (simeprevir) to treat those with genotype 1 of hepatitis C who have compensated liver disease, including...

Simeprevir demonstrated greater efficacy than the current line of hepatitis C drugs among those with genotype and who had compensated liver d...

Those coinfected with HIV and genotype 3 of hepatitis C responded about the same to interferon and ribavirin as those with only hep C in a tri...

Victrelis, when added to interferon and ribavirin, improves cure rates of hepatitis C and does not raise major treatment risks in those coinfe...

Faldaprevir with pegylated interferon and ribavirin cured about 80 percent of treatment-naive people with genotype 1 of hepatitis C in a Phase...

The investigational NS3/4A protease inhibitor simeprevir cured four out of five people with genotype 1 of hepatitis C and compensated liver di...

Janssen has submitted its investigational agent simeprevir to the U.S. Food and Drug Administration for approval for treatment of genotype.

Gilead Sciences has submitted its once-daily oral nucleotide analogue sofosbuvir to the U.S. Food and Drug Administration (FDA) for approval